Core Points - The meeting emphasized the need to deepen the reform of drug regulation in China [1] - The approach will focus on "early intervention, tailored strategies for each enterprise, comprehensive guidance, and collaborative review" throughout the entire process [1] - The goal is to enhance communication and support the development of innovative drugs and medical devices [1]